Panel: Are GEMMs Worth the Investment? Evaluating Their Value in Cancer Research
Time: 1:30 pm
day: Conference Day Two
Details:
- Evaluating whether the significant financial and logistical investment in GEMMs yields reliable, actionable insights that justify their use in drug discovery
- Investigating the gap between GEMM preclinical results and clinical trial outcomes, questioning their true predictive capacity for human patient responses
- Discussing the evolving role of GEMMs in precision oncology, exploring their potential to refine personalized medicine strategies in drug discovery and clinical trials
